Today was the first appearance of India’s #DCGI on a public platform after the WHO suspended the supply of #BharatBiotech’s #Covaxin to UN due to quality issues it found in its manufacturing practises, in March this year (1/n)
It was at @CPR_India dialogues series where the discussion was happening about regulation of various health aspects in India. I asked him ( at 1.01.20) since WHO had already submitted the inspection report; also the Bharat Biotech’s corrective plan and
WHO’s rejection of it, would he divulge the key findings of both reports (submitted in Apr and Jul) and since this was the issue of larger public interest, would he like to put these reports in public domain?
His reply: During pandemic, we could have an indigenous vaccine…after initial capacities of manufactures were exhausted, expansion and plant upgradation was needed… it takes time.. corrective action doesn’t happen overnight. For full reply, refer to his ans at 1.00.04 in video
All vaccine manufacturers expanded their capacities after a point. ALL. Out of 11 WHO approved vaccines, only #covaxin has been suspended due to deficiencies in good manufacturing practises. Therefore it was difficult to make sense of his answer.
He said not a word about findings, that was asked; forget about the way forward since the suspension still holds and WHO said in July to @TheWireScience that manufacturing practises remain “unacceptable”. The vaccine continues to be used in India.
On the sidelines, he asked me why should not the WHO share the report with you (why put onus on CDSCO) when I told him the WHO told @TheWireScience in April and in July it is only a country’s drug regulatory authority that can share the reports.
He also claimed it was “just a draft report” and all was well. Asked, why not put that in public domain saying it was a draft he did not say much.
WHO has never said it was a draft rpt and if it was draft it ought to have been challenged which never happened.
But he didn’t say that CDSCO was did not have these reports or was not aware of it — something what CDSCO said in RTI replies to @PriyankaPulla and @OfficialSauravD.
Saurav’s complaint case in CIC against CDSCO PIO for lying on record in RTI led CIC issuing a show-cause notice.
This was @TheWireScience report in August on WHO’s continued suspension that was put in place in April. WHO said it had rejected company’s corrective action plan and manufacturing practises continued to remain unsatisfactory google.com/amp/s/science.…
This was the April report of @TheWireScience that went into the details of suspension and what possible violations of good manufacturing practises could mean.
It's 4 months into suspension already but WHO is still not satisfied with company's good manufacturing practises (GMPs), it told me last Friday, sharing its assessment of corrective and preventive action (CAPA) plan submitted by company in June. Here's what the WHO exactly said:
"In summary, based on the said CAPA response, the manufacturing site for Covaxin is still considered to be operating at an unacceptable level of compliance with WHO Good Manufacturing Practices for Pharmaceutical Products guidelines,"
Replying my four RTI applications in 2019, @Pharmadept gave me names of 20 pharma firms, which the govt knew, had bribed the docs. This was info ON RECORD. But not a single company got punished. (1/n) downtoearth.org.in/news/health/th…
But @Pharmadept refused to name the docs bribed, saying, it would be seek permission of those who made complaints against docs. When I also reached to original complainants, they had no obj. Still DoP nvr shared names. Asked what action did it take, it said, ask @MoHFW_INDIA
@MoHFW_INDIA said the companies are part of associations of pharma companies. 'We can't do anything, only this assns can'. And what they can? Guess what,remove them from assn.That's all. But that almost never happens. Neither DoP nor ministry told me what action was finally taken
Eight years of #Modi rule: How did the government perform in #health sector. Thread (1/n)
DISEASE ELIMINATION DEADLINES
Kala-azar: 2017. Revised 2020 ❌
Leprosy: 2018 ❌
Filariasis: 2017 ❌
Now, new deadlines for KA: 2023. Filariasis: 2030
TB elimination deadline: 2025
Interim target to be achieved till 2020: 142 per 100,000
But prevalence in 2019-21: 312 per 100,000
NUTRITION TARGETS FOR POSHAN ABHIYAN LAUNCHED in 2018
Anaemia to⬇️3% PA. Instead it⬆️not only in children but also women b/w NFHS-4 and NFHS-5.
Stunting had to ⬇️ to 25% by 2022. But till 2021 it stood at 35.5%. Now it hs ⬇️ to by at least 10% pts in a yr -- an impossible target.
The #WHO on April 2 issued a statement saying the supply of #Covaxin to UN agencies had been suspended due to "deficiencies in good manufacturing practices". There were not mny details. In an email, they have now told @TheWireScience the following : science.thewire.in/health/who-cov… (1/n)
"Problems were detected in some parts of the manufacturing process. SOME CHANGES WERE MADE after the emergency-use license was granted but were not submitted to the national drug regulator and WHO for evaluation and validation."
The WHO still didn't specify what were those changes. Whether those changes were related to increase the yield, or on the front of raw materials or due to some other reason--we don't know. A GMP expert said major changes, if done post approval, have to be informed.
TRUST DRUG CONTROLLER: Paul's response in @MoHFW_INDIA press conference today, responding to a question why no data in public domain on #Corbevax @TheWireScience
Paul: "Corbevax, clearly, the EUA has been given for adult and children. Be rest assured that the data has been by drug regulator. Be also rest assured for both these groups is being reviewed by the NTAGI because we work in tandem."+
UNTIMELY death of a loved one, even if it has happened more than a decade ago, is an extremely difficult fact to come to terms with. Two days ago a friend and I, out of nowhere, went discussing about last 11 days of another friend who died for want of a liver transplant+
She was our batchmate during graduation at a Varanasi univ. She continued to pursue Master’s from there, I moved to Delhi. We were 21. One fine day during our PG days, we got to know she was suffering from liver cirrhosis—otherwise a totally fit person.
This was 4 days after she got was with ‘jaundice' and we kept talking—we thought it would be just fine.
4 days later got a call saying ur friend has bcm unconsciousness from somebody who knew her. I dialled friends in the univ.With their help she got admitted at the varsity hosp